साँचा:एंटीथ्रोम्बोटिक्स देवासंAntithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01)Antiplatelet drugsGlycoprotein IIb/IIIa inhibitorsAbciximab • Eptifibatide • TirofibanADP receptor/P2Y12 inhibitorsthienopyridines (Clopidogrel, Prasugrel, Ticlopidine) • Ticagrelor†Prostaglandin analogue (PGI2)Beraprost • Prostacyclin • Iloprost • TreprostinilCOX inhibitorsAcetylsalicylic acid/Aspirin# • Aloxiprin • Carbasalate calcium • Indobufen • TriflusalThromboxane inhibitorsthromboxane synthase inhibitors (Dipyridamole, Picotamide) • receptor antagonist (Terutroban†)Phosphodiesterase inhibitorsCilostazol • Dipyridamole • TriflusalOtherCloricromen • DitazoleAnticoagulantsVitamin K antagonists(inhibit II, VII, IX, X)coumarins: Acenocoumarol • Coumatetralyl • Dicoumarol • Ethyl biscoumacetate • Phenprocoumon • Warfarin 1,3-Indandiones: Clorindione • Diphenadione • Phenindione other: TioclomarolFactor Xa inhibitors(with some II inhibition)Heparin group/glycosaminoglycans/(bind antithrombin)low molecular weight heparin (Bemiparin, Certoparin, Dalteparin, Enoxaparin, Nadroparin, Parnaparin, Reviparin, Tinzaparin) oligosaccharides (Fondaparinux, Idraparinux) heparinoid (Danaparoid, Sulodexide, Dermatan sulfate)Direct Xa inhibitorsxabans (Apixaban, Otamixaban, Rivaroxaban)Direct thrombin (II) inhibitorsbivalent: Hirudin (Bivalirudin, Lepirudin, Desirudin) univalent: Argatroban • Dabigatran • Melagatran‡ • Ximelagatran‡OtherREG1 • Defibrotide • Ramatroban • Antithrombin III • Protein C (Drotrecogin alfa)Thrombolytic drugs/fibrinolyticsplasminogen activators: r-tPA (Alteplase, Reteplase, Tenecteplase) • UPA (Urokinase, Saruplase) • Streptokinase# • Anistreplase • Monteplase other serine endopeptidases: Ancrod • Fibrinolysin BrinaseNon-medicinalCitrate • EDTA • Oxalate#WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III M: MYL cell/phys (coag, heme, immu, gran), csfs rbmg/mogr/tumr/hist, sysi/epon, btst drug (B1/2/3+5+6), btst, trns